Oxalic Acid

Oxalic Acid

SCHEMBL7648052

COc1cc(C(C)=O)ccc1OCC1CN(Cc2ccccc2)CCO1.O=C(O)C(=O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 19/20 0.71
▸ DRD2 P14416 1/20 0.58
▸ SIGMAR1 Q99720 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7648434 0.89 DRD4 (0.89) DRD4DRD2
Oxalic Acid SCHEMBL7651264 0.89 DRD4 (0.91) DRD4DRD2SIGMAR1
Oxalic Acid SCHEMBL7644553 0.86 DRD4 (0.90) DRD4DRD2
Oxalic Acid SCHEMBL6160267 0.85 DRD4 (0.88) DRD4DRD2
Oxalic Acid SCHEMBL6161304 0.85 DRD4 (0.88) DRD4DRD2
Oxalic Acid SCHEMBL6162619 0.85 DRD4 (0.88) DRD4DRD2
Oxalic Acid SCHEMBL6161557 0.84 DRD4 (0.89) DRD4DRD2
Oxalic Acid SCHEMBL6165259 0.83 DRD4 (0.88) DRD4DRD2
SCHEMBL7650342 0.83 DRD4 (1.00) DRD4DRD2SIGMAR1
Oxalic Acid SCHEMBL6163601 0.83 DRD4 (0.89) DRD4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479491-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, ESPECIALLY PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2002-11-12 — — US disclosed
US-6207662-B1 USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA NEUROSEARCH A/S (DK) 2001-03-27 — — US disclosed
EP-0920423-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1999-06-09 — — EP disclosed
WO-1998007710-A1 DISUBSTITUTED MORPHOLINE, OXAZEPINE OR THIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROSEARCH A/S (DK) 1998-02-26 — — WO disclosed
Send feedback